On June 5, the pharmaceutical network was banned by the whole country: gangliosine. 

 

On June 2, the state administration of food and drug administration issued a statement on the suspension of the use of a single sialic acid in the sale of a four-part silosiosioside sodium chloride injection (no. 69 in 2017). 

 

▍ process of alleged illegal, the disabled, banned imports 

 

The general administration said it was conducting an on-site inspection of the foreign production of imported drugs, and the production of a single sialic acid tetrasylic acid, which was produced by TrbPharmaIndQuimica E Farmaceutica Ltda. Production process with the registration process, quality and safety of significant risk, alleged violation of the "drugadministration law of the People's Republic of China and its implementing regulations and other laws and regulations. 

 

In order to ensure the safety of the public administration decided to this day, stop using the product sales in China, port of the food and drug administration in suspension of the product import customs clearance documents, and organize the process in accordance with the law. 

 

According to the general administration's announcement, the product is called "reinventing jie". It is banned for 5 ml: 100 mg, 2 ml: 20 mg and 2. 

 

▍ 800 yuan per unit 

 

According to public data, the country of origin of the "rebranding" ganglion is Brazil. In the late 1990s, it was approved by the state food and drug administration (SFDA) and introduced in China. Domestic price (hubei) large specifications: 812.47 yuan; Small specifications for each box (5) : 815 yuan. 

 

It is one of the best-selling drugs in the country. Despite not performing well in global markets, some drugs are widely used in China, and sales are staggering. 

 

According to the China health statistics, the market for domestic grade hospitals in 2016 was 119.5 billion yuan (the same as in retail terminal prices). In 2016, the annual sales of the variety in grade hospitals exceeded 10 billion yuan for the first time. 

 

▍ and 11 drugs, has also been banned 

 

When it comes to this product, there is a topic that is not around the past that is the aid. 

 

According to a number of provinces and cities, this product often makes the list. This means that it will be monitored, but the monitoring is not so obvious based on the growth of its sales. Of course, there may be a lot to do with the sales base. 

 

This is not the first time the administration has said no to imported drugs. 

 

On August 30, 2016, the administration issued a notice, the survey found that Italy "gura set (), reduced glutathione sodium for injection" suspected unauthorized changes outside the actual production enterprises, has been suspended the import and sale, and continue to organize relevant issues for this product in the investigation. 

 

In addition, 10 other drugs have been banned. As shown in figure: 

 

 

 

(note: on March 22, 2013, the state food and drug administration (SFDA) was renamed the state administration of food and drug administration (CFDA).